Kela 65 Scheme And Digital Health Will Broaden Patient Access
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
03 Aug 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
€12.76
17.1% undervalued intrinsic discount15 Aug
€10.58
1Y
6.2%7D
0.2%